CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Micropep taps tiny proteins to make pesticides safer

From TechCrunch

By Tim De Chant, Rebecca Szkutak

July 24, 2024

Micropep taps tiny proteins to make pesticides safer

Micropep taps tiny proteins to make pesticides safer

Farmers have got to do something about pests. But nobody really likes the idea of using more chemical pesticides. Thomas Laurent’s company, Micropep, thinks the answer might already be in the plants themselves.

Micropep is exploring how naturally occurring compounds, known as micropeptides, might work as an entirely new class of pesticides. If the startup succeeds, its products promise to be more effective and less toxic than existing synthetic pesticides.

Micropeptides are small proteins, fewer than 100 amino acids long. For years, researchers ignored the genes coded for these proteins, thinking they were too small to do anything meaningful. They were wrong. Micropeptides are helpful for many things, including organ development and communication within and between cells. Perhaps most useful, they can act as switches within a cell, telling which functions to turn on and off.

When it comes to fighting pests and pathogens, such fine control can be pretty useful. Micropep’s first approach is most similar to that employed by antibiotics. The startup’s first products can be sprayed on the leaves of soybean plants. There, it will wait for specific fungi to land on the leaves. When a fungal spore lands and begins to grow, the micropeptide will target the fungus’s cell membrane, forcing it to self-destruct.

If Micropep can make it work, the potential impact could be significant. Agriculture is responsible for about a quarter of greenhouse gases worldwide. Pests consume about 20–30% of all major crops. As the world heats up, insect pests alone will eat up to 25% more grai for every degree Celsius of warming. In other words, pests make agriculture less efficient and climate change super charges them, all of which makes ag’s climate impact that much bigger.

Still, the company faces several challenges before the first farmer can buy Micropep at the supply store. For one, micropeptides don’t fare well in the wild. When they hit the soil, enzymes produced by microbes break them down quickly. To cope with that, the company has been exploring a number of strategies to help its micropeptides last longer.

First, Micropep will start above the soil, with the product for soybean leaves. “We found ways to optimize it so that it remains stable for a few days. But in the soil the persistence is very, very brief,” Laurent said.

To find more durable micropeptides, the startup has developed a series of models that allow it to predict the behavior of various candidates. This year, it will test 1,000 to 2,000 of the most promising ones in the lab. From there, the best 50 to 100 will be deployed in greenhouse trials.

“The final stage for efficacy is going into the field,” Laurent said. “We’re running field trials, and for that, there’s a much smaller number of lead candidates that are interesting.”

The company is currently working through regulatory trials in the U.S., Brazil and Europe, Laurent said. Micropep plans to have its products in regulatory review by 2026 with the hope that they will be live in the U.S. and Brazil by 2028 and Europe by 2030.

In a future generation of Micropep’s technology, micropeptides will also help boost a plant’s natural ability to fight invaders. But just like how battling a virus exhausts people, warding off pests and pathogens saps a plant’s energy. The trick is to turn it on the right defenses at just the right time.

Laurent said that Micropep will partner with different companies that can use the ingredients in their products, as opposed to developing the products itself, to find better reach in a diverse and spread out market.

“It’s a very, very, very fragmented market and highly competitive,” Laurent said. “You have different species of crops, some farmers are growing soy and some farmers who are growing grapes. So you need to find ways to get to those different customers.”

Micropep recently raised a $29 million Series B round led by Zebra Impact Investors and BPI Green Tech Investments. Existing investors including Fall Line Capital, FMC Ventures and Sofinnova Partners also participated, among others. Laurent said the funding is being used for Micropep’s go to market strategy.

Most Recent

Dream Labs raises $90M to help build more intelligent robots with simple video feeds

Dream Labs, a startup trying to make robots more intelligent and capable of performing many different tasks, has raised $90 million in seed funding to coincide with the launch of a public application programming interface that provides access to its universal robot foundation model. Today’s round wa

Oct 19, 2026

Seattle ag-tech startup Carbon Robotics reduces workforce, citing economic conditions

Carbon Robotics, the Seattle-based agricultural technology startup known for its AI-powered, laser-weeding farm implements, has trimmed its workforce. The company did not disclose the total number of layoffs, but confirmed to GeekWire on Monday that the cuts affected employees across multiple depart

Oct 19, 2026

Trump administration orders ban on DeepSeek in federal agencies

The Department of Homeland Security has ordered artificial intelligence technology from the Chinese company DeepSeek Ltd. be removed from all federal civilian agencies. The order, published on the Federal Register website today, warned that DeepSeek’s AI models present “multiple threat vectors,” tha

Oct 19, 2026

AI work assistant startup Town secures unicorn status after raising $108M just weeks after launching

Town.com Inc., an artificial intelligence agent startup laser focused on getting work done by collaborating with other AI agents, revealed today that it has raised $108 million in a new funding at a $1 billion valuation. The Series B round was led by Forerunner Ventures and Menlo Ventures, and saw p

Oct 19, 2026

Similar Posts

Juniper Ventures spins out of Climate Capital to invest in synthetic biology for the climate

There’s a mismatch in climate tech investing: Well over half of all dollars invested since 2020 have flowed into startups working on energy and transportation, according to Sightline Climate. “It’s awesome to see those solutions doing well,” Michael Luciani, founding partner at Juniper, told TechCrunch. But as he points out, those sectors represent less than half of all carbon pollution. “The big contributors are how we make things, the industrials and chemicals and plastics, as well as food an

Dec 23, 2024

How one AI startup is helping rice farmers battle climate change

Mitti Labs is working with The Nature Conservancy to expand the use of climate-friendly rice farming practices in India. The startup uses its AI to verify reductions in methane emissions.

Aug 26, 2025

Teen founders raise $6M to reinvent pesticides using AI — and convince Paul Graham to join in

Bindwell applies AI drug discovery techniques to invent new pesticide molecules.

Nov 13, 2025

French clean tech startup Calyxia nets $35M to tackle microplastics pollution

French clean tech startup Calyxia has profitability within sight. The company just raised a $35 million Series B round that will help it further ramp up industrial production of its sustainable alternatives to microparticles and microcapsules, setting it on the path to net profitability by 2026. But co-founder and CEO Jamie Walters says the B Corp is just getting started. The “starter” problem Calyxia is tackling is staggering at global scale: Microplastics are polluting everything around the w

Sep 5, 2024